Sumitomo Mitsui Trust Group Inc. Has $39.53 Million Stake in Healthpeak Properties, Inc. $DOC

Sumitomo Mitsui Trust Group Inc. increased its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 4.2% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,406,046 shares of the real estate investment trust’s stock after acquiring an additional 97,710 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in Healthpeak Properties were worth $39,531,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of DOC. New York Life Investment Management LLC grew its stake in shares of Healthpeak Properties by 65.8% in the 4th quarter. New York Life Investment Management LLC now owns 156,086 shares of the real estate investment trust’s stock valued at $2,510,000 after buying an additional 61,952 shares during the period. Northside Capital Management LLC raised its stake in Healthpeak Properties by 47.7% during the 4th quarter. Northside Capital Management LLC now owns 472,337 shares of the real estate investment trust’s stock worth $7,595,000 after buying an additional 152,579 shares during the period. Oak Thistle LLC bought a new position in Healthpeak Properties in the fourth quarter worth approximately $3,938,000. Baillie Gifford & Co. boosted its holdings in Healthpeak Properties by 613.2% in the fourth quarter. Baillie Gifford & Co. now owns 367,256 shares of the real estate investment trust’s stock worth $5,905,000 after acquiring an additional 315,763 shares in the last quarter. Finally, HF Advisory Group LLC acquired a new stake in Healthpeak Properties in the fourth quarter valued at approximately $1,517,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Insider Buying and Selling

In related news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the transaction, the insider owned 7,636 shares in the company, valued at approximately $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.23% of the company’s stock.

Healthpeak Properties Stock Up 0.2%

Healthpeak Properties stock opened at $21.69 on Monday. Healthpeak Properties, Inc. has a fifty-two week low of $15.70 and a fifty-two week high of $22.13. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96. The firm’s 50-day simple moving average is $20.10 and its 200 day simple moving average is $18.04. The stock has a market cap of $14.96 billion, a PE ratio of 67.80, a price-to-earnings-growth ratio of 3.36 and a beta of 1.02.

Healthpeak Properties (NYSE:DOC) last released its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. The company had revenue of $752.95 million for the quarter, compared to analysts’ expectations of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The business’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period in the previous year, the business posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Research analysts predict that Healthpeak Properties, Inc. will post 1.75 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently declared a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be issued a $0.1017 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 5.6%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties’s payout ratio is 381.25%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. Weiss Ratings upgraded Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, May 8th. Scotiabank lifted their price target on shares of Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a research report on Wednesday, May 27th. Royal Bank Of Canada boosted their price target on shares of Healthpeak Properties from $20.00 to $21.00 and gave the company an “outperform” rating in a research note on Thursday, May 14th. Mizuho lifted their price objective on shares of Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, July 6th. Finally, Citigroup boosted their target price on shares of Healthpeak Properties from $17.50 to $20.00 and gave the stock a “neutral” rating in a research report on Tuesday, May 12th. Four equities research analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the stock. According to data from MarketBeat, Healthpeak Properties presently has an average rating of “Hold” and a consensus target price of $20.50.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.